AWN-31519-69866
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 112 / NY
- Registered
- 2022-07-24
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-02
Dose 1 — Moderna
-
2022-07-24
Registered in v-safe
- 2022-07-24
-
2022-07-30
Dose 2 — Moderna
- 2022-07-30
-
2022-07-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2022-08-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-08-02
- 2022-08-06
- 2022-08-13
- 2022-08-20
-
2022-09-05
Survey response — day 35, dose 2MedDRA: Joint swelling, Peripheral swelling — Feeling: GoodFree text: Severe swelling in the ankles and feet.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-12
- 2022-10-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-02 | Moderna | No |
| 2 | 2022-07-30 | Moderna | No |
Free text
Release 12 — day 35, dose 2
Symptoms: Severe swelling in the ankles and feet.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Joint swelling | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release